SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

LUNGHI, Barbara
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.440
AS - Asia 3.747
EU - Europa 2.007
SA - Sud America 579
AF - Africa 96
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 3
Totale 13.876
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.287
SG - Singapore 1.369
CN - Cina 901
VN - Vietnam 452
BR - Brasile 433
DE - Germania 370
IT - Italia 355
UA - Ucraina 329
HK - Hong Kong 312
GB - Regno Unito 214
TR - Turchia 186
FR - Francia 126
FI - Finlandia 125
BD - Bangladesh 121
JP - Giappone 113
PL - Polonia 100
SE - Svezia 91
CA - Canada 79
RU - Federazione Russa 78
IN - India 76
ID - Indonesia 56
MX - Messico 56
AR - Argentina 51
NL - Olanda 51
BE - Belgio 35
ZA - Sudafrica 33
IQ - Iraq 31
EC - Ecuador 24
PK - Pakistan 22
ES - Italia 21
CO - Colombia 18
CZ - Repubblica Ceca 18
AT - Austria 16
MY - Malesia 15
VE - Venezuela 15
PH - Filippine 14
CH - Svizzera 13
LT - Lituania 13
CL - Cile 12
DZ - Algeria 12
JO - Giordania 10
MA - Marocco 10
PY - Paraguay 10
SA - Arabia Saudita 9
GR - Grecia 8
IR - Iran 8
RO - Romania 8
NP - Nepal 7
TN - Tunisia 7
UZ - Uzbekistan 7
KE - Kenya 6
PE - Perù 6
UY - Uruguay 6
ET - Etiopia 5
JM - Giamaica 5
PT - Portogallo 5
AL - Albania 4
AU - Australia 4
CI - Costa d'Avorio 4
IE - Irlanda 4
IL - Israele 4
LB - Libano 4
TW - Taiwan 4
AE - Emirati Arabi Uniti 3
AO - Angola 3
BG - Bulgaria 3
BO - Bolivia 3
EG - Egitto 3
KR - Corea 3
KW - Kuwait 3
NO - Norvegia 3
OM - Oman 3
RS - Serbia 3
SK - Slovacchia (Repubblica Slovacca) 3
SN - Senegal 3
SV - El Salvador 3
AZ - Azerbaigian 2
BH - Bahrain 2
BY - Bielorussia 2
DO - Repubblica Dominicana 2
EU - Europa 2
HU - Ungheria 2
PR - Porto Rico 2
SI - Slovenia 2
TH - Thailandia 2
UG - Uganda 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BN - Brunei Darussalam 1
BW - Botswana 1
CG - Congo 1
CR - Costa Rica 1
DK - Danimarca 1
EE - Estonia 1
GD - Grenada 1
GH - Ghana 1
HN - Honduras 1
HR - Croazia 1
IS - Islanda 1
KG - Kirghizistan 1
KZ - Kazakistan 1
Totale 13.861
Salva come PNG Salva come JPEG
Città #
Singapore 843
Ashburn 812
Woodbridge 595
Fairfield 594
San Jose 436
Houston 395
Chandler 369
Jacksonville 345
Santa Clara 345
Hong Kong 305
Beijing 285
Seattle 264
New York 254
Ann Arbor 239
Dallas 222
Wilmington 213
Cambridge 194
Ho Chi Minh City 166
Tokyo 108
Ferrara 102
Izmir 102
Munich 101
Hanoi 99
Nanjing 99
Warsaw 96
Los Angeles 94
Boardman 93
Princeton 84
The Dalles 77
Lauterbourg 73
Council Bluffs 64
San Diego 60
Milan 55
São Paulo 46
Orem 45
Shanghai 40
Helsinki 39
Jakarta 39
Dearborn 37
Shenyang 36
Buffalo 35
Chicago 35
London 35
Mexico City 35
Brussels 34
Bremen 31
Hefei 30
Tianjin 26
Hebei 24
Frankfurt am Main 23
Chennai 22
Turku 22
Brooklyn 21
Johannesburg 21
Phoenix 21
Jiaxing 20
Nanchang 19
Rome 19
Toronto 19
Nuremberg 18
Redwood City 18
Montreal 17
Changsha 16
Da Nang 16
Haiphong 16
Amsterdam 15
Denver 15
Stockholm 15
San Francisco 14
Brno 13
Kunming 13
Mountain View 13
Norwalk 13
Atlanta 12
Auburn Hills 12
Des Moines 12
Düsseldorf 12
Manchester 12
Mcallen 12
Baghdad 11
Curitiba 11
Dong Ket 11
Falkenstein 11
Moscow 11
Vienna 11
Belo Horizonte 10
Hangzhou 10
Poplar 10
Ottawa 9
Redmond 9
Amman 8
Ankara 8
Biên Hòa 8
Boston 8
Charlotte 8
Jinan 8
Lahore 8
Montréal 8
Mumbai 8
San Mateo 8
Totale 9.435
Salva come PNG Salva come JPEG
Nome #
C6orf10 low-frequency and rare variants in italian multiple sclerosis patients 358
An integrated genomic-transcriptomic approach supports a role for the proto-oncogene BCL3 in atherosclerosis 301
Activated factor VII-antithrombin complex predicts mortality in patients with stable coronary artery disease: a cohort study 287
A highly polymorphic microsatellite in the factor V gene is an informative tool for the study of factor V-related disorders 263
Combinations of 4 mutations (FV R506Q, FV H1299R, FV Y1702C, PT 20210G/A) affecting the prothrombinase complex in a thrombophilic family 255
VITAMIN K-INDUCED MODIFICATION OF COAGULATION PHENOTYPE IN VKORC1 HOMOZYGOUS DEFICIENCY 253
Changes in expression profiles of internal jugular vein wall and plasma protein levels in multiple sclerosis 252
Factor XI rs2036914 gene polymorphism and occurrence of adverse events after percutaneous coronary intervention. A prospective evaluation. 248
A novel mutation (Leu817Pro) causing type 2A von Willebrand disease 247
A heparin cofactor II mutation (HCII Rimini) combined with factor V Leiden or type I protein C deficiency in two unrelated thrombophilic subjects 246
Genetic determinants of activated factor VII antithrombin complex plasma concentration include tissue factor, factor VII and endothelial protein C receptor gene variants 246
A factor V genetic component differing from factor V R506Q contributes to the activated protein C resistance phenotype 240
Asymptomatic carriership of factor V Leiden and genotypes of the fibrinogen gene cluster 221
Apolipoprotein C-III Strongly Correlates with Activated Factor VII-Anti-Thrombin Complex: An Additional Link between Plasma Lipids and Coagulation 221
A missense mutation (Y1702C) in the coagulation factor V gene is a frequent cause of factor V deficiency in the italian population 217
Mutation pattern in clinically asymptomatic coagulation factor VII deficiency 217
Polymorphisms at LDLR locus may be associated with coronary artery disease through modulation of coagulation factor VIII activity and independently from lipid profile 214
The factor V Glu1608Lys mutation is recurrent in familial thrombophilia 211
A new factor V gene polymorphism (His 1254 Arg) present in subjects of African origin mimics the R2 polymorphism (His 1299 Arg) 208
FV multiallelic marker detects genetic components of APC resistance contributing to venous thromboembolism in FV Leiden carriers 207
Cis-segregation of c.1171c>t stop codon (p.r391*) in serpinc1 gene and c.1691g>a transition (p.r506q) in f5 gene and selected gwas multilocus approach in inherited thrombophilia 202
Molecular bases of CRM+ factor X deficiency: a frequent mutation (Ser334Pro) in the catalytic domain and a substitution (Glul02Lys) in the second EGF‐like domain 200
A novel factor V null mutation detected in a thrombophilic patient with pseudo-homozygous APC resistance and in an asymptomatic unrelated subject 200
Mutations in the R2 FV gene affect the ratio between the two FV isoforms in plasma 199
Performance prediction models based on anthropometric, genetic and psychological traits of Croatian sprinters 199
The F11 rs2289252 polymorphism is associated with FXI activity levels and APTT ratio in women with thrombosis 193
Interaction of occupational posture, lifestyle and genetic components of thrombophilia 192
Prospective evaluation of on-clopidogrel platelet reactivity over time in patients treated with percutaneous coronary intervention: Relationship with gene polymorphisms and clinical outcome 190
Expression profiles of the internal jugular and saphenous veins: Focus on hemostasis genes 190
Expression Profiles of the Internal Jugular and Saphenous Veins: Focus on Hemostasis Genes 190
An Italian Family with a Novel Mutation Causing Type 2A von Willebrand Disease and with Reduced Levels of von Willebrand Factor not Linked with the von Willebrand Factor Gene. 188
An underestimated combination of opposites resulting in enhanced thrombotic tendency 183
The factor VIII D I24I E polymorphism is associated with decreased factor VIII activity and not with activated protein C resistance levels 179
Factor V gene mutations (R2 gene) are associated with coronary artery disease inelderly people 178
Increased factor VIII coagulant activity levels in male carriers of the factor V R2 polymorphism 176
Detection of new polymorphic markers in the factor V gene: Association with factor V levels in plasma 172
Predictive value of D-dimer test for recurrent venous thromboembolism after anticoagulation withdrawal in subjects with a previous idiopathic event and in carriers of congenital thrombophilia 166
Does factor V Asp79His (409 G/C) polymorphism influence factor V and APC resistance levels? 162
Factor V markers for the detection of genetic components of APC resistance in venous thrombosis 162
New coagulation factor V gene polymorphisms define a single and infrequent haplotype underlying the factor V leiden mutation in Mediterranean populations and Indians 161
Modulation of factor V levels in plasma by polymorphisms in the C2 domain 153
Hemostasis gene expression of the internal jugular and saphenous veins 153
Resistance to activated protein C, associated with oral contraceptives use; effect of formulations, duration of assumption, and doses of oestro- progestins 151
Risks factors for highly unstable response to oral anticoagulation: a case-control study 150
Factor V markers for the detection of genetic components of APC resi stance in venous thrombosis. 149
Novel phenotype and gamma-glutamyl carboxylase mutations in combined deficiency of vitamin K-dependent coagulation factors 149
Venous thromboembolism in young women - Role of thrombophilic mutations and oral contraceptive use 148
The Asialoglycoprotein Receptor Minor Subunit Gene Contributes to Pharmacokinetics of Factor VIII Concentrates in Hemophilia A 143
Contribution of asialoglycoprotein receptor ASGR2 5’ UTR polymorphisms to full-length FVIII concentrate pharmacokinetics 142
Factor V Levels in a Cohort of Patients Eligible for Oral Anticoagulant Therapy. 141
F9 missense mutations impairing factor IX activation are associated with pleiotropic plasma phenotypes 139
Combination of Genomic and Transcriptomic Approaches Highlights Vascular and Circadian Clock Components in Multiple Sclerosis 137
Phenotype and genotype expression in pseudohomozygous factor V-LEIDEN - The need for phenotype analysis 137
Functional genetics 137
Resistance to activated protein C in healthy women taking oral contraceptives 136
Phenotypic homozygous activated protein C resistance associated with compound heterozygosity for Arg506Gln (factor V Leiden) and His1299 Arg substitutions in factor V 136
CMR+ Factor V deficiency Arg2080Cys: A model to investigate altered C2 domain-membrane interaction. 136
Combination of CLEC4M rs868875 G-Carriership and ABO O Genotypes May Predict Faster Decay of FVIII Infused in Hemophilia A Patients 134
Molecular basis of coagulation factor V deficiency caused by the R1698W inter-domain mutation. 132
Aptamer-modified FXa generation assays to investigate hypercoagulability in plasma from patients with ischemic heart disease 130
Expression of the normal factor V allele modulates the APC resistance phenotype in heterozygous carriers of the factor V Leiden mutation 127
Increased Susceptibility to Proteases in Type 2A von Willebrand Disease Associated with two Novel Mutations (Val 867 Glu, Pro 864 His). 122
In vivo modulation of a dominant-negative variant in mouse models of von Willebrand disease type 2A 122
Molecular bases of pseudo-homozygous APC resistance: The compound heterozygosity for FV R506Q and a FV null mutation results in the exclusive presence of FV Leiden molecules in plasma 120
Polimorfismi funzionali e terapia anticoagulante 117
Severe bleeding and absent ADP-induced platelet aggregation associated with inherited combined CalDAG-GEFI and P2Y12 deficiencies 111
Contribution of low density lipoprotein receptor-related protein genotypes to coagulation factor VIII levels in thrombotic women 105
Functional polymorphisms in the LDLR and pharmacokinetics of Factor VIII concentrates 105
The p.P1127S pathogenic variant lowers von Willebrand factor levels through higher affinity for the macrophagic scavenger receptor LRP1: Clinical phenotype and pathogenic mechanisms 103
Whole-Exome Sequencing in a Family with an Unexplained Tendency for Venous Thromboembolism: Multicomponent Prediction of Low-Frequency Variant Deleteriousness and of Individual Protein Interaction 102
The asymptomatic carriership of thrombophilic defects is associated with frequent genotypes of the fibrinogen gene cluster. 102
The asialoglycoprotein receptor ASGR2 5’ UTR polymorphisms influence several parameters of full-length FVIII concentrate pharmacokinetics 101
Evaluation of FV mRNA to define the residual FV expression levels in severe FV deficiency 96
null 95
Expression and characterization of a factor V mutation (E1608K) detected in familial thrombophilia. 95
Lesioni molecolari ricorrenti sono responsabili di difetti funzionali del fattore VII. 89
Studio di mutazioni in geni dell’emostasi. 89
null 88
Detection of New Polymorphic Markers in the Factor V Gene. 88
Studio di Mutazioni in Geni dell'Emostasi. 86
Selected cell receptor genotypes differentially modulate the ABO blood group influence on Factor VIII levels in severe aortic stenosis 80
In vitro and ex vivo rescue of a nonsense mutation responsible for severe coagulation factor V deficiency 75
Modulation of factor VIII pharmacokinetics by genetic components in factor VIII receptors 66
null 63
Influence of low-density lipoprotein (LDL) receptor-related protein and ABO blood group genotypes on factor XI levels. 63
Association of membranous nephropathy with familial resistance to activated protein C 62
Factor V Kuwait alias factor V R3: A rare polymorphism of uncertain functional significance 53
Genetic components in factor VIII receptors for individual and genotype-modeled hemophilia A treatment 30
Reduced inhibition of activated prothrombin by heparin and venous thromboembolism: heparin resistance revisited 20
Genetic determinants of activated factor VII-antithrombin plasma levels and mortality in patients with coronary artery disease 16
Totale 14.018
Salva come PNG Salva come JPEG
Categoria #
all - tutte 63.081
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 63.081
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202156 0 0 0 0 0 0 0 0 0 0 0 56
2021/2022903 96 87 47 71 50 18 54 47 21 59 83 270
2022/2023902 93 78 24 109 130 130 67 76 100 15 46 34
2023/2024563 34 39 18 20 36 183 9 26 17 7 13 161
2024/20251.870 44 31 172 66 243 169 46 77 316 219 275 212
2025/20265.492 524 222 523 704 758 356 620 311 547 537 277 113
Totale 14.018